Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Department of Clinical and Health Psychology, St James's University Hospital, Leeds, UK.
J Psychosoc Oncol. 2022;40(4):407-424. doi: 10.1080/07347332.2021.1955318. Epub 2021 Nov 26.
The aim of this work was to co-develop an Acceptance and Commitment Therapy (ACT) intervention to support medication adherence and quality of life in breast cancer survivors (BCSs). The research approach was intervention co-development.
The sample consisted of BCS focus groups (n = 24), health care provider (HCP) interviews (n = 10), and a co-development workshop (BCSs, n = 12; HCPs, n = 9).We conducted 6 BCS focus groups and 10 HCP interviews to understand the acceptability of ACT. We co-designed the intervention in a workshop.
Participants reported high acceptability of an ACT intervention. BCSs preferred ACT exercises focused on values and self-compassion. Both groups recommended face-to-face intervention delivery, by a clinical psychologist, with a mixture of individual and group sessions. BCSs requested advice on side-effect management.
We effectively used patient and HCP co-design to configure an ACT intervention to support medication adherence and quality of life for BCSs. If feasible and efficacious, this ACT-based intervention could support breast cancer survivorship.
本研究旨在共同开发一种接受和承诺疗法（ACT）干预措施，以支持乳腺癌幸存者（BCS）的药物依从性和生活质量。研究方法为干预共同开发。
该样本包括乳腺癌焦点小组（n=24）、医疗保健提供者访谈（n=10）和共同开发研讨会（BCS，n=12；HCP，n=9）。我们进行了 6 个乳腺癌焦点小组和 10 个医疗保健提供者访谈，以了解 ACT 的可接受性。我们在研讨会上共同设计了干预措施。
参与者报告了对 ACT 干预措施的高度可接受性。BCS 更喜欢关注价值观和自我同情的 ACT 练习。两组均建议由临床心理学家通过个体和小组会议的混合方式进行面对面的干预交付。BCS 请求有关副作用管理的建议。
我们有效地使用了患者和医疗保健提供者的共同设计来配置 ACT 干预措施，以支持 BCS 的药物依从性和生活质量。如果可行且有效，这种基于 ACT 的干预措施可以支持乳腺癌的生存。
